Targeting endoplasmic reticulum stress: a novel therapeutic strategy for neuropathic pain
-
By
-
Yang Niu
-
Jiayu Han
-
Tao Song
-
Xueshu Tao
-
June 4, 2026
-
Clinical Scorecard: Addressing Endoplasmic Reticulum Stress: An Innovative Approach to Treat Neuropathic Pain
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Endoplasmic reticulum stress, neuroinflammation, apoptosis, and the unfolded protein response (UPR) |
| Target Population | |
| Care Setting | |
Key Highlights
- ER stress is a central mechanism in neuropathic pain pathogenesis.
- Activation of UPR disrupts cellular homeostasis, leading to neuroinflammation and cell death.
- Targeting ER stress may improve management of neuropathic pain.
- ER stress signaling is cell-type specific, affecting neurons, glial cells, and immune cells.
- Current first-line treatments have limited efficacy and adverse effects.
- The complexity of ER stress signaling poses challenges for clinical translation.
Guideline-Based Recommendations
Diagnosis
- Consider neuropathic pain in patients with lesions or diseases of the somatosensory system.
Management
- Explore ER stress-targeted therapies as potential treatment options.
- Assess the duration of ER stress in patients to tailor treatment.
Monitoring & Follow-up
- Monitor for signs of neuroinflammation and pain hypersensitivity.
Risks
- Prolonged ER stress activation can lead to inflammation and cell death.
Patient & Prescribing Data
Patients with chronic neuropathic pain conditions.
Current treatments include gabapentinoids and antidepressants, but they often have limited efficacy.
Clinical Best Practices
- Assess the role of ER stress in individual patients with neuropathic pain.
- Consider immune and glial cell involvement in pain mechanisms.
- Evaluate the potential for novel therapies targeting ER stress pathways.
- Incorporate patient-specific factors when assessing ER stress roles.
Related Resources & Content
